stoxline Quote Chart Rank Option Currency Glossary
  
Aclarion, Inc. (ACON)
0.293  0.001 (0.21%)    07-16 11:06
Open: 0.2923
High: 0.2957
Volume: 28,603
  
Pre. Close: 0.2924
Low: 0.291
Market Cap: 2(M)
Technical analysis
2024-07-16 10:47:20 AM
Short term     
Mid term     
Targets 6-month :  0.35 1-year :  0.37
Resists First :  0.3 Second :  0.31
Pivot price 0.29
Supports First :  0.26 Second :  0.22
MAs MA(5) :  0.29 MA(20) :  0.29
MA(100) :  0.33 MA(250) :  3.46
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  50.9 D(3) :  62.5
RSI RSI(14): 46.4
52-week High :  11.5 Low :  0.26
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ACON ] has closed above bottom band by 35.2%. Bollinger Bands are 92.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 86 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.31 - 0.31 0.31 - 0.32
Low: 0.28 - 0.28 0.28 - 0.29
Close: 0.29 - 0.29 0.29 - 0.3
Company Description

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Headline News

Tue, 16 Jul 2024
Aclarion, Inc. (NASDAQ:ACON) Short Interest Down 6.1% in June - Defense World

Thu, 25 Apr 2024
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - ReAlpha Tech Corp (NASDAQ:AIRE), Aclarion (NASDAQ:ACON) - Benzinga

Thu, 25 Apr 2024
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain - OrthoSpineNews

Thu, 25 Apr 2024
ACON Stock Price and Chart — NASDAQ:ACON - TradingView

Mon, 26 Feb 2024
Gold Moves Lower; Pilgrim's Pride Earnings Top Views - Benzinga

Mon, 26 Feb 2024
Why Is Aclarion (ACON) Stock Down 19% Today? - InvestorPlace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 0 (M)
Shares Float 8 (M)
Held by Insiders 8.04e+006 (%)
Held by Institutions 1.1 (%)
Shares Short 225 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -4.8e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -12 %
Return on Assets (ttm) 609.3 %
Return on Equity (ttm) -111.2 %
Qtrly Rev. Growth 60050 %
Gross Profit (p.s.) -125.63
Sales Per Share -703.19
EBITDA (p.s.) 0
Qtrly Earnings Growth -13.5 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0.4
Stock Dividends
Dividend 0
Forward Dividend 312490
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android